Avinger, Inc. (AVGR)

NASDAQ: AVGR · IEX Real-Time Price · USD
3.420
-0.130 (-3.66%)
Feb 23, 2024, 3:57 PM EST - Market closed

Company Description

Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) in the United States and internationally.

It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.

The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, including Ocelot and Tigereye, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients.

In addition, its chronic total occlusion (CTO)-crossing catheters, Wildcat and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO.

Further, the company develops IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists.

The company was incorporated in 2007 and is headquartered in Redwood City, California.

Avinger, Inc.
Avinger logo
Country United States
Founded 2007
IPO Date Jan 30, 2015
Industry Medical Instruments & Supplies
Sector Healthcare
Employees 71
CEO Jeffrey M. Soinski

Contact Details

Address:
400 Chesapeake Drive
Redwood City, California 94063
United States
Phone 650-363-2400
Website avinger.com

Stock Details

Ticker Symbol AVGR
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001506928
CUSIP Number 053734604
ISIN Number US0537348775
Employer ID 20-8873453
SIC Code 3841

Key Executives

Name Position
Jeffrey M. Soinski President, Chief Executive Officer and Director
Nabeel P. Subainati Vice President of Finance, Principal Financial Officer and Accounting Officer
Himanshu N. Patel Chief Technology Officer
Keith Schaefer Chief Operating Officer

Latest SEC Filings

Date Type Title
Feb 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Jan 26, 2024 8-K Current Report
Jan 10, 2024 S-8 Securities to be offered to employees in employee benefit plans
Dec 29, 2023 8-K Current Report
Dec 22, 2023 8-K Current Report
Dec 12, 2023 8-K Current Report
Dec 1, 2023 8-K/A [Amend] Current report
Dec 1, 2023 8-K Current Report
Nov 27, 2023 8-K Current Report
Nov 22, 2023 DEF 14A Other definitive proxy statements